Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Washington University School of Medicine
Novartis
Incyte Corporation
University of Kansas Medical Center
Roswell Park Cancer Institute
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center